LENOX, MA--(Marketwire - February 28, 2008) - You may think doctors make decisions based on medical evidence, but in reality most negative drug study results are hidden from doctors by the food and drug administration (FDA), leaving doctors in the dark about your medications.

A recent report in The New England Journal of Medicine found that more than half of all the negative studies on antidepressants were never published, giving a false sense of effectiveness of antidepressants to treat depression; and now it's come to light that the FDA approved the cholesterol-lowering drug Zetia without any proof that it lowered heart attacks or reduced the progression of heart disease.

Zetia was approved by the FDA and given to 5 million people before Zetia's makers finally performed studies and released negative data that found Zetia didn't reduce heart attacks, but actually increased fatty plaques in the arteries despite lowering cholesterol, leading to more heart disease.

"When a drug company designs and performs a study, it must be registered and all results must be submitted to the FDA," said Mark Hyman, M.D. of UltraWellness. "But instead, pharmaceutical companies have only been submitting the data they want to get published to medical journals, hiding any negative studies from the scientific community and from the public. Drug companies tend not to publish negative studies on drugs, only positive ones."

Drug studies that are sponsored by drug companies have positive outcomes at four times the rate of independently funded studies. Also, what gets researched in drug studies depends on who is funding it. Since drug companies fund most of the research in the world, other therapies that work better -- such as diet and lifestyle or nutritional therapies -- never get enough funding.